|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0030705,
umls-concept:C0032183,
umls-concept:C0038952,
umls-concept:C0085862,
umls-concept:C0229671,
umls-concept:C0281361,
umls-concept:C1299583,
umls-concept:C1549571,
umls-concept:C1608386,
umls-concept:C1861172,
umls-concept:C2698872
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2010-10-8
|
|
pubmed:abstractText |
Improved diagnostic, predictive, and prognostic biomarkers for pancreatic ductal adenocarcinoma (PDAC) are urgently needed. Platelet factor 4 (PF4) has been proposed as a diagnostic biomarker for PDAC. We assessed the diagnostic and prognostic potential of serum PF4 levels in PDAC patients.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
1538-7755
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
©2010 AACR.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
19
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2605-10
|
|
pubmed:dateRevised |
2011-10-3
|
|
pubmed:meshHeading |
pubmed-meshheading:20729288-Adult,
pubmed-meshheading:20729288-Aged,
pubmed-meshheading:20729288-Aged, 80 and over,
pubmed-meshheading:20729288-Carcinoma, Pancreatic Ductal,
pubmed-meshheading:20729288-Case-Control Studies,
pubmed-meshheading:20729288-Cohort Studies,
pubmed-meshheading:20729288-Diagnosis, Differential,
pubmed-meshheading:20729288-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:20729288-Female,
pubmed-meshheading:20729288-Humans,
pubmed-meshheading:20729288-Male,
pubmed-meshheading:20729288-Middle Aged,
pubmed-meshheading:20729288-Pancreatic Neoplasms,
pubmed-meshheading:20729288-Pancreatitis, Chronic,
pubmed-meshheading:20729288-Platelet Factor 4,
pubmed-meshheading:20729288-Prognosis,
pubmed-meshheading:20729288-Survival Analysis,
pubmed-meshheading:20729288-Treatment Outcome,
pubmed-meshheading:20729288-Tumor Markers, Biological,
pubmed-meshheading:20729288-Venous Thromboembolism
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Serum platelet factor 4 is an independent predictor of survival and venous thromboembolism in patients with pancreatic adenocarcinoma.
|
|
pubmed:affiliation |
Department of Surgery, University of Utah School of Medicine, Salt Lake City, Utah, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, N.I.H., Extramural
|
